Mgr. Tomáš Loja, Ph.D.
Technical specialist, Genomics Core Facility
Office: bldg. E35/234
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 7455 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 107
2023
-
Identification of novel targets that upregulate CD20 expression in rituximab-resistant cells with the use of genomewide CRISPR screening.
Year: 2023, type: Conference abstract
-
Inhibition of acute myeloid leukemia using palbociclib and ponatinib in a patient-derived xenograft model.
Year: 2023, type: Conference abstract
-
The role of casein kinase 1 inhibition in treatment of chronic lymphocytic leukemia.
Year: 2023, type: Conference abstract
2022
-
GAB1 as novel therapeutic target in B lymphoid and myeloid malignancies
Year: 2022, type: Conference abstract
-
Sekvenování dlouhých nekódujících RNA v exozomech u pacientů s kolorektálním karcinomem
Klinická onkologie, year: 2022, volume: 35, edition: Supplementum 1, DOI
-
Versatile coculture systém to study chronic lymhocytic leukemia proliferation.
Year: 2022, type: Conference abstract
2021
-
Acute myeloid leukemia regression induced by palbociclib and ponatinib in patient –derived xenograft model.
Year: 2021, type: Conference abstract
-
Detekce transpozibilních elementů u hematologických malignit.
Year: 2021, type: Conference abstract
-
Disruption of NAP1 genes in Arabidopsis thaliana suppresses the fas1 mutant phenotype, enhances genome stability and changes chromatin compaction
The Plant Journal, year: 2021, volume: 106, edition: 1, DOI
-
FoxO1-GAB1 axis regulates homing capacity and tonic AKT activity in chronic lymphocytic leukemia
Blood, year: 2021, volume: 138, edition: 9, DOI